News & Events

Press Releases

Show All

March 2012

March 28, 2012 Cellular Dynamics Expands Distribution Agreement with iPS Academia Japan, Inc. to Include Distribution of iCell Neurons and iCell Endothelial Cells in Japan

MADISON, WI, March 28, 2012—Cellular Dynamics International, Inc. (CDI) today announced an expansion of its existing distribution agreement  with iPS Academia Japan, Inc. to include iCell® Neurons and iCell Endothelial Cells. The original distribution agreement, announced on June 8, 2011, covered the distribution of CDI’s iCell Cardiomyocytes, the first commercially available product based on induced…

March 8, 2012 Presentations at the Society of Toxicology Annual Meeting Demonstrate Superior Predictivity of Cellular Dynamics’ Induced Pluripotent Stem Cell-derived Human Cell Models for Drug Discovery and Toxicity TestingDownload PDF

MADISON, WI, March 8, 2012—Cellular Dynamics International, Inc. (CDI), the world’s largest commercial producer of human induced pluripotent stem (iPS) cell lines and tissue cells for drug discovery and safety, today announced several customer presentations of studies employing the company’s iCell®products at the Society of Toxicology (SOT) Annual Meeting on March 11 to 15 in San…